Literature DB >> 14510900

Endocrine intervention for transsexuals.

Andy Levy1, Anna Crown, Russell Reid.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14510900     DOI: 10.1046/j.1365-2265.2003.01821.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  10 in total

Review 1.  Gender identity and sport: is the playing field level?

Authors:  J C Reeser
Journal:  Br J Sports Med       Date:  2005-10       Impact factor: 13.800

2.  SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders.

Authors:  A Godano; M Maggi; E Jannini; M C Meriggiola; E Ghigo; O Todarello; A Lenzi; C Manieri
Journal:  J Endocrinol Invest       Date:  2009-11       Impact factor: 4.256

Review 3.  Cross-sex hormone therapy for gender dysphoria.

Authors:  B Fabris; S Bernardi; C Trombetta
Journal:  J Endocrinol Invest       Date:  2014-11-18       Impact factor: 4.256

4.  Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages.

Authors:  Mathijs C Bunck; Miguel Debono; Erik J Giltay; Andreas T Verheijen; Michaela Diamant; Louis J Gooren
Journal:  BMJ Case Rep       Date:  2009-08-10

5.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

6.  The eunuchs of India: An endocrine eye opener.

Authors:  Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2012-05

7.  Effects of testosterone treatment on hypothalamic neuroplasticity in female-to-male transgender individuals.

Authors:  Georg S Kranz; Andreas Hahn; Ulrike Kaufmann; Martin Tik; Sebastian Ganger; René Seiger; Allan Hummer; Christian Windischberger; Siegfried Kasper; Rupert Lanzenberger
Journal:  Brain Struct Funct       Date:  2017-08-17       Impact factor: 3.270

8.  Outcome and preferences in male-to-female subjects with gender dysphoria: Experience from Eastern India.

Authors:  Anirban Majumder; Debmalya Sanyal
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

9.  Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India.

Authors:  Anirban Majumder; Debmalya Sanyal
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun

10.  Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.

Authors:  Flávia Siqueira Cunha; Sorahia Domenice; Maria Helena Palma Sircili; Berenice Bilharinho de Mendonca; Elaine Maria Frade Costa
Journal:  Clinics (Sao Paulo)       Date:  2018-05-03       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.